À̴뼿ﺴ¿ø ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è Á¤±â ½ÉÆ÷Áö¾ö : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : À̴뼿ﺴ¿ø ´ë°´ç
±³À°ÁÖÁ¦ : ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è Á¤±â ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸²ÇÁÁ¾¿¬±¸È¸
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-29 ´ë°´ç 10:00~10:30 Pathologic review of primary cutaneous T cell lymphoma ÇÑÀçÈ£(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 10:40~11:05 Treatment of Mycosis Fungoides - perspective dermatology ÀÌÀ¯Áø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 11:05~11:30 Treatment of Mycosis Fungoides - perspective hematology ÃÖÀ±¼®(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 11:45~12:10 Sezary syndrome: what makes it different MF and how to treat? ÀÌÁöÀ±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 13:20~13:45 SPTCL(Subcutaneous panniculitis-like T-cell lymphoma)and Primary cutaneous gamma/delta T cell lymphoma: how are they different in pathobiology? ÀüÀ±°æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 13:45~14:10 SPTCL(Subcutaneous panniculitis-like T-cell lymphoma) and primary cutaneous gamma/delta T cell lymphoma: therapeutic approaches Á¶Çö¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 14:20~14:45 Hepatosplenic T cell lymphoma: clinicopathologic features and treatment ±è»ó¾Æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 14:50~15:15 Blastic plasmacytoid dendritic cell neoplasm: clinicopathologic features and treatment ÀÌÁöÇö(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 15:40~16:05 Nodal TFH(T follicular helper) cell lymphoma - differential diagnosis and pathobiology Á¶ÁØÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 16:05~16:30 Nodal TFH(T follicular helper) cell lymphoma - different therapeutic approaches PTCL(Peripheral T-cell lymphoma), NOS? ÀÌÁØÈ£(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 04-29 ´ë°´ç 16:45~17:10 Update on novel therapies for PTCL(Peripheral T-cell lymphoma): recent progress in the treatment ±è´ë½Ä(°í·ÁÀÇ´ë)